Default company panoramic image
Ca314cce 6096 4ac4 a72d 9d7afba99872


NE201, Phase Two drug to treat OSAS.

  • Stage Not Set
  • Industry Biotechnology
  • Location Champaign, IL, USA
  • Currency USD

Company Summary

Utilizing Nanotechnology to make ordinary drugs extraordinary therapies. Our therapy will effectively treat the underlying pathology of OSAS , reduce the morbidity and mortality associated with this lethal disease.